Yanmei Hu
Rutgers, The State University of New Jersey(US)Kyushu University(JP)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Chengdu University of Technology(CN)Chengdu University of Traditional Chinese Medicine(CN)South China University of Technology(CN)Taiyuan University of Technology(CN)
Publications by Year
Research Areas
RNA and protein synthesis mechanisms, SARS-CoV-2 and COVID-19 Research, Computational Drug Discovery Methods, Influenza Virus Research Studies, Viral Infections and Immunology Research
Most-Cited Works
- → Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease(2020)877 cited
- → Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L(2020)392 cited
- → Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir(2023)294 cited
- → Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors(2020)270 cited
- → Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay(2021)195 cited
- → The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor